Tennis elbow treatment showdown ends early
NCT ID NCT02325063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared three different injections—platelet-rich plasma, botulinum toxin, and steroids—for treating tennis elbow pain. It aimed to see which worked best for pain relief. Only 13 people took part before the study was stopped early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPICONDYLITIS, LATERAL HUMERAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Montpellier - Hôpital Lapeyronie
Montpellier, 34295, France
-
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over elbow: can beliefs predict how tennis elbow patients respond to treatment?
- Keyhole vs open surgery for tennis elbow: which offers better pain relief?
- New combo therapy for tennis elbow shows promise in small trial
- Botox for tennis elbow? new study tests pain relief
- Wrist or shoulder? study tests best exercise for tennis elbow relief
- Shockwave or simple exercises? new study aims to settle tennis elbow debate